These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32864414)

  • 1. Mild cognitive impairment in Aboriginal Australians.
    Derrig H; Lavrencic LM; Broe GA; Draper B; Cumming RG; Garvey G; Hill TY; Daylight G; Chalkley S; Mack H; Lasschuit D; Delbaere K; Radford K
    Alzheimers Dement (N Y); 2020; 6(1):e12054. PubMed ID: 32864414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia Incidence,
    Lavrencic LM; Delbaere K; Broe GA; Daylight G; Draper B; Cumming RG; Garvey G; Allan W; Hill TY; Lasschuit D; Schofield PR; Radford K
    Neurology; 2022 Mar; 98(11):e1124-e1136. PubMed ID: 35140131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion pattern and predictive factor of mild cognitive impairment in elderly Koreans.
    Shim SM; Song J; Kim JH; Jeon JP
    Arch Gerontol Geriatr; 2016; 64():146-50. PubMed ID: 26896864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia.
    Jungwirth S; Zehetmayer S; Hinterberger M; Tragl KH; Fischer P
    Int Psychogeriatr; 2012 Jun; 24(6):959-66. PubMed ID: 22300486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between depressive symptoms and subtypes of mild cognitive impairment in post-menopausal women: Results from the Women's Health Initiative Memory Study.
    Korthauer LE; Goveas JS; Rapp SR; Espeland MA; Shumaker SA; Garcia KR; Rossom RC; Garcia L; Tindle HA; Salmoirago-Blotcher E; Wassertheil-Smoller S; Zaslavsky O; Cochrane B; Sink KM; Masaki K; Driscoll I
    Int J Geriatr Psychiatry; 2022 Nov; 37(11):. PubMed ID: 36205005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved.
    Espinosa A; Alegret M; Valero S; Vinyes-Junqué G; Hernández I; Mauleón A; Rosende-Roca M; Ruiz A; López O; Tárraga L; Boada M
    J Alzheimers Dis; 2013; 34(3):769-80. PubMed ID: 23271318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
    Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of diabetes with amnestic and nonamnestic mild cognitive impairment.
    Roberts RO; Knopman DS; Geda YE; Cha RH; Pankratz VS; Baertlein L; Boeve BF; Tangalos EG; Ivnik RJ; Mielke MM; Petersen RC
    Alzheimers Dement; 2014 Jan; 10(1):18-26. PubMed ID: 23562428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and mild cognitive impairment in the general population: results of the Heinz Nixdorf recall study.
    Dlugaj M; Winkler A; Dragano N; Moebus S; Jöckel KH; Erbel R; Weimar C;
    J Alzheimers Dis; 2015; 45(1):159-74. PubMed ID: 25471191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of mild cognitive impairment of Alzheimer's disease by Simoa p-tau181 measurements with matching plasma and CSF.
    Wu L; Arvai S; Wang SJ; Liu AJ; Xu B
    Front Mol Neurosci; 2023; 16():1288930. PubMed ID: 38260807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker-Based Prediction of Progression to Dementia: F-18 FDG-PET in Amnestic MCI.
    Tripathi M; Tripathi M; Parida GK; Kumar R; Dwivedi S; Nehra A; Bal C
    Neurol India; 2019; 67(5):1310-1317. PubMed ID: 31744965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationships Between Components of Metabolic Syndrome and Mild Cognitive Impairment Subtypes: A Cross-Sectional Study of Japanese Older Adults.
    Bae S; Shimada H; Lee S; Makizako H; Lee S; Harada K; Doi T; Tsutsumimoto K; Hotta R; Nakakubo S; Park H; Suzuki T
    J Alzheimers Dis; 2017; 60(3):913-921. PubMed ID: 28922149
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.